• SENSEX 73,895.74
    315.20 (+0.43%)
  • BANKNIFTY 55,580.40
    141.90 (+0.26%)
  • ICICI Bank
    1,311.70 1,187.55(%)
  • NSE
    1,790.00 1,790.00(%)
  • SS Retail
    692.30 603.00(%)
  • PB Fintech.
    1,115.10 1,115.10(%)
  • The Bombay Burmah
    1,425.75 1,301.00(%)
  • Hero Motors
    141.85 141.85(%)
  • Whirlpool India
    959.60 1,438.30(%)
  • Cholaman.Inv.&Fn
    1,638.05 1,299.80(%)
  • Larsen & Toubro
    3,885.90 4,440.00(%)
  • Tour. Fin. Corp.
    135.55 51.20(%)
  • Kotak Mah. Bank
    399.35 345.40(%)
  • AU Small Finance
    1,021.20 1,144.65(%)
  • Infosys
    991.75 984.00(%)
  • Rainbow Child.
    1,351.50 1,008.75(%)
  • Kaveri Seed Co.
    844.00 1,139.90(%)
  • Cupid
    274.15 298.95(%)
  • Reliance Industries
    1,227.20 1,611.20(%)
  • HDFC Bank
    739.50 1,020.35(%)
  • Shanti Gold
    333.00 333.00(%)
  • Tata Consumer
    979.10 979.10(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Mankind Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 38451.0
  • ISIN : INE634S01028
2,474.90 -25 (-1.00%)
  • As on 26 Sep 2026 (EOD)

  • Today’s Low

    2,454.40

  • Today’s High

    2,504.60

  • Open

    2,488.30

  • Perv Close

    2,500.00

  • 52W Low

    1,909.70

  • 52W High

    2,642.00

Key Indicators

  • P/E(TTM)

    45.21

  • Mar.Cap (₹Cr.)

    102,224.53

  • Div & Yield %

    0.04

  • Book Value(₹)

    396.98

  • Debt-Equity Ratio

    -1.00

  • AGM Date

    25-Sep-2026

  • EPS

    54.75

  • P/E Ratio

    45.21

Financials Ratios

  • Debt-Equity Ratio

    0.02

  • Mar.Cap (₹Cr.)

    102,224.53

  • RONW (%)

    23.12

  • ROCE (%)

    27.89

Score Board

  • Equity (₹ in Cr.)

    41.30

  • BV (₹)

    397.00

  • Sales( ₹ in Cr.)

    10,421.18

  • NP (in Cr.)

    2,125.16

  • NP Var(%)

    32.0

  • Div%

    100.0

  • CPS (₹)

    61.80

  • EPS (₹)

    51.50

  • Traded Value (₹ in Lakhs)

    102,247.25

  • 52 Week High

    2,642.00

  • 52 Week Low

    1,909.70

  • Price BSE

    2475.0

  • Price NSE

    2,475.00

  • Market Capital( in Cr.)

    102,247.25

  • P/C Ratio

    40.00

  • P/E Ratio

    48.10

  • Price Vs.BV

    51.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 10,421.18 9,507.41 8,629.25 8,127.15 7,486.22 5,529.60
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 10,421.18 9,507.41 8,629.25 8,127.15 7,486.22 5,529.60
Other Income 326.10 554.65 374.03 162.78 203.81 148.08
Stock Adjustments -35.37 13.68 48.20 -267.89 365.27 254.25
Total Income 10,711.91 10,075.74 9,051.48 8,022.04 8,055.30 5,931.93
EXPENDITURE :            
Raw Materials 2,589.80 2,618.16 2,618.31 2,576.87 2,886.71 2,036.42
Power and Fuel Cost 97.78 89.14 80.91 62.00 60.36 47.16
Employee Cost 2,367.04 2,148.87 1,921.09 1,701.38 1,462.76 1,106.14
Other Manufacturing Expenses 234.66 211.70 145.78 113.62 93.57 56.71
Selling and Administration Expenses 1,905.45 1,773.61 1,518.78 1,539.07 1,378.52 966.82
Miscellaneous Expenses 211.11 254.27 125.69 168.47 131.08 192.07
Employee Benefit Expenses 2,367.04 2,148.87 1,921.09 1,701.38 1,462.76 1,106.14
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 7,405.84 7,095.75 6,410.56 6,161.40 6,013.00 4,405.31
Operating Profit 3,306.07 2,979.99 2,640.92 1,860.65 2,042.30 1,526.62
Interest 562.50 377.50 16.93 28.23 47.54 8.23
Gross Profit 2,743.57 2,602.49 2,623.99 1,832.42 1,994.76 1,518.39
Depreciation 428.57 394.76 335.26 269.58 123.33 78.19
Profit Before Tax 2,315.00 2,207.73 2,288.73 1,562.84 1,871.43 1,440.20
Current Tax 473.22 469.93 411.33 291.64 429.03 346.99
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -195.78 -48.19 1.24 22.94 52.98 8.84
Reported Net Profit 2,037.56 1,785.99 1,876.16 1,248.26 1,389.42 1,084.37
Extraordinary Items -87.60 180.81 105.89 29.02 62.07 30.15
Adjusted Net Profit 2,125.16 1,605.18 1,770.27 1,219.24 1,327.35 1,054.22
Adjustment below Net Profit 38.21 -153.08 -6.66 -4.86 -0.79 -1.56
P & L Balance brought forward 11,396.88 9,763.97 7,894.47 6,624.90 5,236.27 3,747.13
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 41.27 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 13,431.38 11,396.88 9,763.97 7,868.30 6,624.90 4,829.95
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 100.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 1.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 49.36 43.29 46.83 31.16 34.68 27.07
Earnings Per Share(Adj)-Unit Curr 49.36 43.29 46.83 - - -
Book Value 397.21 347.13 242.21 194.31 163.27 118.18
Book Value(Adj)-Unit Curr 397.21 347.13 242.21 - - -

Shareholding Pattern

  • Promoter Group

    72.63%

  • Public Share Holding

    27.37%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 74,921,805 18.14 74,921,805 10
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 225,038,807 54.49 225,038,807 3
Others 0 0.00 0 0
Sub Total 299,960,612 72.63 299,960,612 13
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 8,400 0.00 8,400 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 39,041,918 9.45 39,041,918 501
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 6,358,592 1.54 6,358,592 17
Mutual Funds / UTI 44,889,663 10.87 44,889,663 36
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 12,299,126 2.98 12,299,126 25
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 102,597,699 24.84 102,597,699 581
2] Non Institution
Bodies Corporate 4,287,989 1.04 4,287,989 598
Clearing Members 199,392 0.05 199,392 3
Directors of their Relatives 0 0.00 0 0
Employees 196,682 0.05 196,682 14
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 213,336 0.05 213,336 2,832
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 187,319 0.05 187,319 3,198
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 0 0.00 0 0
Individuals holding nominal share capital up to Rs. 1 lakh 5,321,321 1.29 5,321,321 159,467
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 4,715 0.00 4,715 8
Others 26,913 0.01 26,913 1
Sub Total 10,437,667 2.53 10,437,667 166,121
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 412,995,978 100.00 412,995,978 166,715

Company Background

Mankind Pharma LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Mankind Pharma Ltd
  • BSE Code : 38451.0
  • ISIN : INE634S01028

  • Incorporation Year

    1991

  • Registered Office

    208 Okhla Industrial Estate
    Phase-III, New Delhi,
    New Delhi-110020

  • Telephone

    91-11-47476600

  • FAX

  • Chairman

    RAMESH CHAND JUNEJA

  • Managing Director

  • Company Secretary

    Hitesh Kumar Jain

  • Auditor

    S R Batliboi & Co LLP/Bhagi Bhardwaj Gaur & Co

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Mankind Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Mankind Pharma 2,475.45 10,747.28 10,421.18 46.90 13.07
Abbott India 26,935.80 7,217.19 6,929.05 35.45 43.78
Astrazeneca Phar 6,517.85 2,304.07 2,275.58 96.06 27.86
Glaxosmi. Pharma 2,816.85 3,932.76 3,790.20 45.00 58.17
Novartis India 1,961.40 393.10 354.33 49.53 15.94
Cipla 1,397.20 20,102.60 18,979.95 36.72 13.88
Bliss GVS Pharma 709.30 773.53 729.81 65.92 12.51
Amrutanjan Healt 506.15 520.13 502.55 27.11 24.16
Fermenta Biotec. 468.15 474.15 450.25 21.86 18.77
Guj. Themis Bio. 417.30 168.25 165.82 111.58 18.05
Ambalal Sarabhai 40.55 19.52 3.94 75.09 6.77